Compass Minerals International (CMP) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
23 Jan, 2026Executive summary
The annual meeting is scheduled for March 5, 2026, via virtual webcast, with voting rights for shareholders of record as of January 12, 2026.
Key proposals include electing nine directors for one-year terms, an advisory vote on executive compensation, and ratification of KPMG LLP as the independent auditor for fiscal 2026.
The company emphasizes responsible transformation of natural resources, safety, sustainability, and value creation as core principles.
Voting matters and shareholder proposals
Shareholders will vote on electing nine director nominees, approving executive compensation on an advisory basis, and ratifying KPMG LLP as the independent auditor.
The board recommends voting in favor of all proposals.
Shareholders may submit proposals or director nominations for the 2027 annual meeting within specified timeframes.
Board of directors and corporate governance
The board will be reduced from 12 to nine members following the meeting, with several new appointments and planned retirements.
The board is led by a non-executive chairman and all committees are chaired by independent directors.
Annual board and committee evaluations, director term limits, and proxy access rights are in place.
Board diversity is highlighted, with a mix of skills, backgrounds, and perspectives.
Latest events from Compass Minerals International
- Net loss narrowed, Plant Nutrition margins rose, and full-year EBITDA guidance increased.CMP
Q3 2026 - Q2 2026 delivered higher margins, reduced debt, and strong Plant Nutrition growth.CMP
Q2 2026 - All voting items passed and no stockholder questions were raised during the meeting.CMP
AGM 2026 - Q1 2026 net income hit $18.6M, EBITDA doubled, and guidance was raised on strong salt results.CMP
Q1 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.CMP
Proxy Filing - Net loss narrowed, debt fell, and 2026 guidance targets margin and EBITDA growth.CMP
Q4 2025 - 2024 net loss from impairments; 2025 outlook sees Salt volume growth and stable capex.CMP
Q4 2024 - Revenue up 36% to $494.6M, net loss narrowed, and Fortress exited amid cost actions.CMP
Q2 2025 - Q1 FY2025 revenue down 10%, net loss narrowed, and Plant Nutrition volumes rose.CMP
Q1 2025